(DNP) DNP Select Income - Ratings and Ratios

Exchange: NYSE • Country: USA • Currency: USD • Type: Fund • ISIN: US23325P1049 • Utilities

DNP: Utilities, Real Estate, Energy, Master Limited Partnerships

DNP Select Income Closed Fund, traded on the New York Stock Exchange under the ticker symbol DNP, is a type of investment fund. The fund's ISIN, or International Securities Identification Number, is US23325P1049, which serves as a unique identifier for the fund in the global financial markets. As a closed-end investment fund, DNP has a fixed number of shares that are traded on the open market, unlike open-end funds which can issue new shares as investors put in more money. The fund's style is focused on utilities, indicating that it primarily invests in companies that operate in the utilities sector, such as those involved in the generation, transmission, and distribution of electricity, gas, and water.

The utilities sector is known for its relatively stable and predictable cash flows, which can make it an attractive destination for investors seeking income. DNP Select Income Closed Fund, by concentrating on this sector, aims to provide its shareholders with a regular stream of income, typically in the form of dividends. The fund's investment strategy may involve a combination of equity and debt securities of utilities companies, with the goal of maximizing income while managing risk. By investing in a diversified portfolio of utilities securities, the fund seeks to reduce its exposure to any one particular company or asset, thereby potentially lowering the overall risk for its investors.

As a closed-end fund, DNP's share price can fluctuate based on market forces and may sometimes trade at a discount or premium to its net asset value (NAV). The NAV represents the total value of the fund's assets minus its liabilities, divided by the number of outstanding shares. Investors considering DNP Select Income Closed Fund should be aware of these dynamics and understand that the fund's share price can be influenced by a variety of factors, including the overall performance of the utilities sector, interest rates, and broader market conditions. The fund's management team is responsible for making investment decisions and overseeing the portfolio to achieve the fund's investment objectives.

Additional Sources for DNP Fund

DNP Fund Overview

Market Cap in USD 4,006m
Style Utilities
TER 1.86%
IPO / Inception 1987-01-21

DNP Fund Ratings

Growth 5y 50.5%
Fundamental -
Dividend 71.1%
Rel. Strength Industry -7.85
Analysts -
Fair Price Momentum 10.00 USD
Fair Price DCF -

DNP Dividends

Dividend Yield 12m 9.21%
Yield on Cost 5y 12.56%
Annual Growth 5y 0.00%
Payout Consistency 95.2%

DNP Growth Ratios

Growth Correlation 3m 91.4%
Growth Correlation 12m 76.3%
Growth Correlation 5y 60.4%
CAGR 5y 7.16%
CAGR/Max DD 5y 0.29
Sharpe Ratio 12m 1.63
Alpha 11.13
Beta 0.14
Volatility 15.69%
Current Volume 533.6k
Average Volume 20d 622.2k
What is the price of DNP stocks?
As of March 15, 2025, the stock is trading at USD 9.51 with a total of 533,649 shares traded.
Over the past week, the price has changed by +0.86%, over one month by +1.88%, over three months by +3.67% and over the past year by +15.14%.
Is DNP Select Income a good stock to buy?
Partly, yes. Based on ValueRay Analyses, DNP Select Income (NYSE:DNP) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 50.51 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DNP as of March 2025 is 10.00. This means that DNP is currently overvalued and has a potential downside of 5.15%.
Is DNP a buy, sell or hold?
DNP Select Income has no consensus analysts rating.
What are the forecast for DNP stock price target?
According to ValueRays Forecast Model, DNP DNP Select Income will be worth about 10.8 in March 2026. The stock is currently trading at 9.51. This means that the stock has a potential upside of +13.56%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 10.8 13.6%